GSK amps up AI with Insilico pact | August 28, 2017 Issue - Vol. 95 Issue 34 | Chemical & Engineering News
Volume 95 Issue 34 | p. 15 | Concentrates
Issue Date: August 28, 2017

GSK amps up AI with Insilico pact

Department: Business
Keywords: Biotechnology, Artificial intelligence, AI, GSK

Aiming to bolster its abilities in the hot area of artificial intelligence research, GlaxoSmithKline will collaborate with Insilico Medicine. Under the deal, which follows a pilot pact, GSK will use technology from Baltimore-based Insilico to look for novel biological targets and pathways. Meanwhile, GSK has lost its head of drug discovery and preclinical development, Ian Churcher, to BenevolentBio, a subsidiary of another AI firm, BenevolentAI.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment